Clofarabine

Pharm Company: * ZYDUS PHARMS USA INC
Category: Cancer

Clofarabine is a purine nucleoside antimetabolite marketed in the United States and Canada as Clolar. In Europe and Australia/New Zealand the product is marketed under the name Evoltra. It is FDA-approved for treating relapsed or refractory acute lymphoblastic leukaemia (ALL) in children after at least two other types of treatment have failed. Some investigations of effectiveness in cases of acute myeloid leukaemia (AML) and juvenile myelomonocytic leukaemia (JMML) have been carried out. Ong... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Clofarabine 1 mg/ml Intravenous Injection
NDC: 0955-1746
Labeler:
Sanofi-aventis U.S. LLC
Clofarabine 1 mg/ml Intravenous Injection
NDC: 43598-309
Labeler:
Dr.reddy's Laboratories Inc
Clofarabine 1 mg/ml Intravenous Injection
NDC: 49315-003
Labeler:
Cadila Healthcare Limited
Clofarabine 1 mg/ml Intravenous Injection, Solution
NDC: 50742-512
Labeler:
Ingenus Pharmaceuticals, LLC
Clofarabine 1 mg/ml Intravenous Injection
NDC: 55150-326
Labeler:
Eugia Us LLC
Clofarabine 1 mg/ml Intravenous Injection
NDC: 60505-6166
Labeler:
Apotex Corp.
Clofarabine 1 mg/ml Intravenous Injection
NDC: 63323-572
Labeler:
Fresenius-kabi
Clofarabine 1 mg/ml Intravenous Injection
NDC: 67457-546
Labeler:
Mylan Institutional LLC
Clofarabine 1 mg/ml Intravenous Injection
NDC: 68083-386
Labeler:
Gland Pharma Limited
Clofarabine 1 mg/ml Intravenous Injection
NDC: 70121-1236
Labeler:
Amneal Biosciences LLC

Related Brands

Drugs with the same active ingredients